Clinical Trial Update: Safety and Effectiveness of Intermittent Hypoxia Treatment in Parkinson's Disease [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial results assessing the safety and effectiveness of intermittent hypoxia treatment in Parkinson disease; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Intermittent Hypoxia Treatment

Snippet

Sponsor: Radboud University Medical Center | Conditions: Parkinson Disease | Phase 1, Phase 2 | Status: COMPLETED